We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.74B
AUM Growth
-$335M
Cap. Flow
-$614M
Cap. Flow %
-16.42%
Top 10 Hldgs %
21.69%
Holding
674
New
53
Increased
215
Reduced
238
Closed
121

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$113M
2
INTC icon
Intel
INTC
+$61.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$25.3M
4
CLX icon
Clorox
CLX
+$25.2M
5
TJX icon
TJX Companies
TJX
+$24.2M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$107M
2
AAPL icon
Apple
AAPL
+$71.8M
3
TRV icon
Travelers Companies
TRV
+$27.6M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$27.4M
5
AXP icon
American Express
AXP
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.7%
2 Financials 10.88%
3 Technology 9.76%
4 Communication Services 9.34%
5 Consumer Staples 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECL icon
201
Ecolab
ECL
$75.6B
$4M 0.11%
34,959
+29,033
+490% +$3.41M
RHT
202
DELISTED
Red Hat Inc
RHT
$3.98M 0.11%
47,999
-1,265
-3% -$100K
SYF icon
203
Synchrony
SYF
$23.7B
$3.93M 0.11%
+129,312
New +$4.05M
HALO icon
204
Halozyme
HALO
$9.72B
$3.82M 0.1%
220,600
+91,000
+70% +$1.45M
BN icon
205
Brookfield
BN
$102B
$3.82M 0.1%
346,328
-427,108
-55% -$5.01M
LOW icon
206
Lowe's Companies
LOW
$116B
$3.82M 0.1%
50,264
-125,408
-71% -$9.31M
INSM icon
207
Insmed
INSM
$23.2B
$3.79M 0.1%
208,800
+60,000
+40% +$1.06M
BLUE
208
DELISTED
bluebird bio
BLUE
$3.74M 0.1%
4,493
+1,081
+32% +$1.08M
ACHN
209
DELISTED
Achillion Pharmaceuticals
ACHN
$3.71M 0.1%
344,300
– –
CL icon
210
Colgate-Palmolive
CL
$72.6B
$3.71M 0.1%
55,703
-320,457
-85% -$21.3M
F icon
211
Ford
F
$57.3B
$3.64M 0.1%
258,600
+20,417
+9% +$296K
ROST icon
212
Ross Stores
ROST
$76.6B
$3.64M 0.1%
67,614
+4,605
+7% +$235K
MRTX
213
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$3.63M 0.1%
115,000
+8,000
+7% +$283K
CAT icon
214
Caterpillar
CAT
$409B
$3.62M 0.1%
53,303
-168,453
-76% -$11.8M
VV icon
215
Vanguard Large-Cap ETF
VV
$51.9B
$3.6M 0.1%
38,590
-6,185
-14% -$582K
XYL icon
216
Xylem
XYL
$28.5B
$3.59M 0.1%
98,416
-106,571
-52% -$3.85M
NBL
217
DELISTED
Noble Energy, Inc.
NBL
$3.59M 0.1%
109,033
+13,282
+14% +$464K
RXDX
218
DELISTED
Ignyta, Inc.
RXDX
$3.58M 0.1%
+267,500
New +$3.22M
BAP icon
219
Credicorp
BAP
$30.9B
$3.57M 0.1%
36,700
+18,600
+103% +$2.02M
ACOR
220
DELISTED
Acorda Therapeutics
ACOR
$3.51M 0.09%
683
+42
+7% +$184K
ENTA icon
221
Enanta Pharmaceuticals
ENTA
$372M
$3.5M 0.09%
+106,000
New +$3.45M
TEVA icon
222
Teva Pharmaceuticals
TEVA
$35.9B
$3.48M 0.09%
52,993
-6,000
-10% -$371K
FOSL icon
223
Fossil Group
FOSL
$239M
$3.43M 0.09%
93,881
+59,005
+169% +$2.69M
USB icon
224
US Bancorp
USB
$99.6B
$3.41M 0.09%
79,921
-265,721
-77% -$11.4M
RARE icon
225
Ultragenyx Pharmaceutical
RARE
$2.65B
$3.4M 0.09%
30,280
+4,000
+15% +$400K
7 8
9
10 11

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2015 Portfolio in Review

As of Q4 2015, Candriam SCA held 674 positions worth $3.74B, down 8.2% from $4.07B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA withdrew a net $614M in Q4 2015, closing 121 positions and reducing 238 holdings. Its most notable exit was Amgen, an estimated $107M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in Alphabet (Google) Class A worth $118M.

  • Candriam SCA's largest Q4 2015 buy was Alphabet (Google) Class A: 3,043,280 shares worth $118M.
  • Candriam SCA added most to Intel in Q4 2015, an estimated $61.2M increase.
  • Candriam SCA's biggest Q4 2015 reduction was Colgate-Palmolive, cutting an estimated $21.3M.
  • Candriam SCA fully exited Amgen in Q4 2015, selling an estimated $107M.
  • Candriam SCA's ten largest holdings make up 22% of its $3.74B portfolio in Q4 2015.
  • Candriam SCA opened 53 new positions and closed 121 in Q4 2015.
  • Candriam SCA's portfolio value fell 8.2% quarter-over-quarter to $3.74B.

Based on Candriam SCA's 13F filing for Q4 2015, filed 25 Jan 2016.